The Cancer Society says it was nonsense for Pharmac to suggest the research behind Keytruda was a reason not to fund the drug. We talk to the society's medical director, Chris Jackson.
The Cancer Society says it was nonsense for Pharmac to suggest the research behind Keytruda was a reason not to fund the drug. We talk to the society's medical director, Chris Jackson.